Apotea AB (V30)
XDUS
Delayed Data
Oct 16, 2026, 06:00 AM
Day's Range
8.0052 wk Range
5.07Overview - V30 - Apotea AB
Key Statistics
Valuation
Enterprise Value
300.40M
P/E (Trailing)
‪3.65‬
PEG Ratio
‪0.28‬
Price / Book
‪0.86‬
EV / EBITDA
‪0.63‬
Profitability
Gross Margin
‪27.53%‬
Profit Margin
‪26.89%‬
Operating Margin
‪4.18%‬
Return on Assets
‪11.54%‬
Return on Equity
‪26.59%‬
Ownership
Shares Outstanding
104.07M
Price stats
50-Day Avg
‪7.02‬
200-Day Avg
‪6.50‬
Peers - V30 - Apotea AB
Peer Comparison
Compared with companies in Pharmaceutical Retailers listed on XDUS.
- V30XDUSApotea AB-6.98%52-week change3.65P/E (Trailing)‪26.89%‬Profit Margin
- IV3XDUSPiu Medical S.p.A.-10.86%52-week change29.00P/E (Trailing)‪36.46%‬Profit Margin
- ZREXDUSDocMorris AG+63.14%52-week change-4.91P/E (Trailing)‪22.22%‬Profit Margin
- RDCXDUSRedcare Pharmacy N.V.-21.39%52-week change-38.13P/E (Trailing)‪22.54%‬Profit Margin
- 2LYAXDUSHigh Tide Inc.-27.37%52-week change-3.83P/E (Trailing)‪25.84%‬Profit Margin
- WOLFXDUSMeta Wolf AG-30.00%52-week change—P/E (Trailing)‪58.33%‬Profit Margin
- UGIXDUSSugi Holdings Co., Ltd.-39.44%52-week change0.06P/E (Trailing)‪31.79%‬Profit Margin
Profile Summary - V30 - Apotea AB
About
Apotea AB is Sweden's largest online pharmacy, operating exclusively in the e-commerce space within the healthcare sector. Founded in 2011 and headquartered in Stockholm, the company delivers a vast array of products directly to consumers, including non-prescription and prescription medications, vitamins, dietary…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
